Introduction: Alzheimer's disease (AD) is a daunting public health threat that has prompted
the scientific community's ongoing efforts to decipher the underlying disease mechanism …

It has now been~ 30 years since the Alzheimer's disease (AD) research entered what may
be termed the 'molecular era'that began with the identification of the amyloid β protein (Aβ) …

Alzheimer's disease is the largest unmet medical need in neurology. Current drugs improve
symptoms, but do not have profound disease-modifying effects. However, in recent years …

Therapeutic options for Alzheimer's disease are currently limited to symptomatic treatment
that only provides modest and temporary maintenance of cognitive and memory functions …

Despite decades of intense research, therapeutics for Alzheimer's disease (AD) are still
limited to symptomatic treatments that possess only short-term efficacy. Recently, several …

Introduction: Alzheimer's disease (AD), a commonly encountered neurodegenerative
disorder, causes cognitive decline and has a devastating effect on the quality of life. AD …

No cure or disease-modifying therapy for Alzheimer's disease (AD) has yet been realized.
However, a multitude of pharmacological targets have been identified for possible …

Alzheimer's disease (AD) is a neurodegenerative disease that robs the minds of our elderly
population. Approximately one in every eight adults over the age of 65 and nearly half of …

Introduction Alzheimer's disease (AD) is the main cause of dementia and represents a huge
burden for patients, carers, and healthcare systems. Extensive efforts for over 20 years have …

Alzheimer's disease (AD) is a neurodegenerative brain disorder that has an increasingly
large burden on health and social care systems. The pathophysiology involves the …